The veterinary infectious disease diagnostics market refers to the market for products and services used to diagnose infectious diseases in animals. This includes diagnostic tests, instruments, and software used to detect the presence of viruses, bacteria, fungi, and parasites in animals.
The market for veterinary infectious disease diagnostics is driven by a number of factors, including increasing pet ownership, rising demand for animal-based food products, and a growing awareness of the importance of animal health. In addition, the emergence of new infectious diseases and the need for more effective diagnostic tools are also driving growth in this market.
Geographically, North America is the largest market for veterinary infectious disease diagnostics, followed by Europe and Asia Pacific. Factors driving growth in these regions include a high level of pet ownership, a large livestock industry, and an increasing focus on animal health and welfare.
Overall, the veterinary infectious disease diagnostics market is expected to continue to grow in the coming years, driven by increasing demand for animal health products and services, as well as technological advancements in diagnostic tools and techniques.
Request Sample Report at: https://www.alliedmarketresearch.com/request-sample/6462
According to the report, the global veterinary infectious disease diagnostics industry garnered $1.27 billion in 2018, and is estimated to reach $2.40 billion by 2026, growing at a CAGR of 8.3% from 2019 to 2026.Prime determinants of growth
Increase in ownership of companion animals, surge in animal health expenditure, and demand for pet insurance drive the global veterinary infectious disease diagnostics market. However, lack of veterinary infrastructure in underdeveloped countries hinders the market growth. On the other hand, rise in awareness regarding animal healthcare across the world create new opportunities in coming years.
𝐏𝐫𝐨𝐜𝐮𝐫𝐞 𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 (𝟐𝟐𝟎 𝐏𝐚𝐠𝐞𝐬 𝐏𝐃𝐅 𝐰𝐢𝐭𝐡 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬, 𝐂𝐡𝐚𝐫𝐭𝐬, 𝐓𝐚𝐛𝐥𝐞𝐬, 𝐚𝐧𝐝 𝐅𝐢𝐠𝐮𝐫𝐞𝐬) @ https://www.alliedmarketresearch.com/checkout-final/a10d66eef98bd76765d008651b35f327
The immunodiagnostics segment to maintain its leadership position by 2026
Based on product type, the immunodiagnostics segment contributed to nearly half of the total share of the global veterinary infectious disease diagnostics market in 2018, and is expected to maintain its leadership position throughout the forecast period. Moreover, this segment would portray the highest CAGR of 9.2% from 2019 to 2026.
This is due to benefits related to utilization of these tests including rapid results and accurate diagnosis.The research also analyzes segments including molecular diagnostics and others.
The dogs segment to maintain its lion’s share in terms of revenue by 2026
Based on application, the dogs segment accounted for the largest market share of the global veterinary infectious disease diagnostics market, accounting for more than two-fifths of the total market share in 2018, and is expected to maintain its lion’s share in terms of revenue by 2026. Moreover, this segment is estimated to grow at the highest CAGR of 9.0% from 2019 to 2026. This is due to increase in ownership of dogs as companion animals across the world.The report also discusses segments including cats and others.
North America to maintain its dominance during the forecast period
Based on region, North America accounted for the highest market share in terms of revenue, accounting for nearly two-fifths of the global veterinary infectious disease diagnostics market in 2018, and is estimated to maintain its dominance during the forecast period. This is attributed to rise in awareness regarding early screening of diseases in companion animals and availability of better veterinary treatment options.
Moreover, Asia-Pacific is expected to maintain the highest CAGR of 10.3% from 2019 to 2026, owing to increase in pet ownership and surge in awareness regarding early diagnosing and treatment of diseases occurring in companion animals.
For Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/6462
Leading market players
Biomérieux SA
HESKA Corporation
IDEXX Laboratories, Inc.
ID.Vet
Neogen Corporation
Qiagen N.V.
Randox Laboratories Ltd.
Thermo Fisher Scientific Inc.
VirbacZoetis
𝐎𝐭𝐡𝐞𝐫 𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠 𝐑𝐞𝐩𝐨𝐫𝐭𝐬:
Hearing Amplifiers Market>> https://www.alliedmarketresearch.com/hearing-amplifiers-market-A10990
Hospital-Acquired Infection Control Market>> https://www.alliedmarketresearch.com/hospital-acquired-infection-control-market-A10994
Contact Us:
David Correa
Portland, OR, United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022,
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
About Us:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.